Otis Worldwide Valuation
Is OTIS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of OTIS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: OTIS * (MX$1550) is trading above our estimate of fair value (MX$1222.31)
Significantly Below Fair Value: OTIS * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for OTIS *?
Other financial metrics that can be useful for relative valuation.
What is OTIS *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$37.28b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.1x |
Enterprise Value/EBITDA | 17.5x |
PEG Ratio | 3.8x |
Price to Earnings Ratio vs Peers
How does OTIS *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 38.1x | ||
GCARSO A1 Grupo Carso. de | 24.4x | 26.2% | Mex$312.3b |
SCHN Schindler Holding | 27.1x | 5.4% | CHF24.2b |
IR Ingersoll Rand | 48.4x | 15.9% | US$37.7b |
XYL Xylem | 52.6x | 16.0% | US$32.0b |
OTIS * Otis Worldwide | 26.4x | 7.0% | Mex$37.3b |
Price-To-Earnings vs Peers: OTIS * is good value based on its Price-To-Earnings Ratio (26.4x) compared to the peer average (38.1x).
Price to Earnings Ratio vs Industry
How does OTIS *'s PE Ratio compare vs other companies in the Global Machinery Industry?
Price-To-Earnings vs Industry: OTIS * is expensive based on its Price-To-Earnings Ratio (26.4x) compared to the Global Machinery industry average (21.7x).
Price to Earnings Ratio vs Fair Ratio
What is OTIS *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 26.4x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate OTIS *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,550.00 | Mex$1,679.01 +8.3% | 9.9% | Mex$2,025.38 | Mex$1,344.58 | n/a | 16 |
Apr ’25 | Mex$1,650.97 | Mex$1,618.95 -1.9% | 8.0% | Mex$1,790.04 | Mex$1,346.79 | n/a | 14 |
Mar ’25 | n/a | Mex$1,618.95 0% | 8.0% | Mex$1,790.04 | Mex$1,346.79 | n/a | 14 |
Feb ’25 | n/a | Mex$1,584.16 0% | 7.8% | Mex$1,794.08 | Mex$1,349.83 | n/a | 14 |
Jan ’25 | n/a | Mex$1,535.04 0% | 8.5% | Mex$1,698.86 | Mex$1,308.12 | n/a | 14 |
Dec ’24 | n/a | Mex$1,551.80 0% | 8.2% | Mex$1,746.40 | Mex$1,344.73 | n/a | 14 |
Nov ’24 | n/a | Mex$1,602.59 0% | 8.2% | Mex$1,802.98 | Mex$1,388.29 | n/a | 14 |
Oct ’24 | Mex$1,407.00 | Mex$1,584.99 +12.7% | 8.4% | Mex$1,759.15 | Mex$1,354.55 | n/a | 14 |
Sep ’24 | n/a | Mex$1,548.36 0% | 8.0% | Mex$1,714.41 | Mex$1,337.24 | n/a | 14 |
Aug ’24 | n/a | Mex$1,522.82 0% | 8.0% | Mex$1,686.13 | Mex$1,315.18 | n/a | 14 |
Jul ’24 | n/a | Mex$1,486.86 0% | 8.1% | Mex$1,648.93 | Mex$1,253.88 | n/a | 14 |
Jun ’24 | n/a | Mex$1,522.34 0% | 8.3% | Mex$1,698.09 | Mex$1,291.25 | n/a | 14 |
May ’24 | n/a | Mex$1,530.69 0% | 8.3% | Mex$1,721.15 | Mex$1,308.79 | n/a | 13 |
Apr ’24 | n/a | Mex$1,534.22 0% | 9.4% | Mex$1,772.46 | Mex$1,343.34 | Mex$1,650.97 | 13 |
Mar ’24 | n/a | Mex$1,534.22 0% | 9.4% | Mex$1,772.46 | Mex$1,343.34 | n/a | 13 |
Feb ’24 | Mex$1,515.00 | Mex$1,517.38 +0.2% | 8.4% | Mex$1,708.70 | Mex$1,291.01 | n/a | 13 |
Jan ’24 | Mex$1,515.00 | Mex$1,535.66 +1.4% | 9.6% | Mex$1,775.71 | Mex$1,282.46 | n/a | 12 |
Dec ’23 | n/a | Mex$1,481.05 0% | 9.2% | Mex$1,731.10 | Mex$1,250.24 | n/a | 12 |
Nov ’23 | n/a | Mex$1,516.56 0% | 9.2% | Mex$1,783.30 | Mex$1,287.94 | n/a | 13 |
Oct ’23 | n/a | Mex$1,583.58 0% | 8.8% | Mex$1,802.32 | Mex$1,301.68 | Mex$1,407.00 | 13 |
Sep ’23 | n/a | Mex$1,583.58 0% | 8.8% | Mex$1,802.32 | Mex$1,301.68 | n/a | 13 |
Aug ’23 | n/a | Mex$1,604.07 0% | 8.2% | Mex$1,793.80 | Mex$1,324.97 | n/a | 13 |
Jul ’23 | n/a | Mex$1,711.13 0% | 11.0% | Mex$2,013.09 | Mex$1,389.03 | n/a | 13 |
Jun ’23 | n/a | Mex$1,702.86 0% | 10.2% | Mex$1,983.62 | Mex$1,448.04 | n/a | 13 |
May ’23 | n/a | Mex$1,783.01 0% | 10.2% | Mex$2,040.24 | Mex$1,489.38 | n/a | 13 |
Apr ’23 | n/a | Mex$1,835.81 0% | 9.5% | Mex$2,110.93 | Mex$1,467.60 | n/a | 13 |
Analyst Forecast: Target price is less than 20% higher than the current share price.